GSK-3β inhibitor 12

CAS No. 784170-07-6

GSK-3β inhibitor 12( —— )

Catalog No. M35424 CAS No. 784170-07-6

GSK-3β inhibitor 12 is a selective GSK-3β inhibitor.GSK-3β inhibitor 12 inhibits 49.11% of 25 μM GSK-3β activity and 37.11% of 50 μM GSK-3β activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 123 In Stock
10MG 202 In Stock
25MG 353 In Stock
50MG 492 In Stock
100MG 685 In Stock
200MG 918 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GSK-3β inhibitor 12
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK-3β inhibitor 12 is a selective GSK-3β inhibitor.GSK-3β inhibitor 12 inhibits 49.11% of 25 μM GSK-3β activity and 37.11% of 50 μM GSK-3β activity.
  • Description
    GSK-3β inhibitor 12 (compound 15) is an inhibitor of GSK-3β. GSK-3β inhibitor 12 inhibits 49.11% and 37.11% activity of 25 μM and 50 μM GSK-3β, respectively. GSK-3β inhibitor 12 can be used for the research of neurodegenerative diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    GSK-3
  • Recptor
    GSK-3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    784170-07-6
  • Formula Weight
    271.34
  • Molecular Formula
    C14H13N3OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=CN=C(NC(=O)CC2=CNC3=CC=CC=C23)S1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Martinez Gil A, et al. N-(2-Thiazolyl)-amide derivatives as GSK-3 inhibitors. EP20060380099. 2007
molnova catalog
related products
  • CHIR-99021 monohydro...

    A potent, specific GSK-3 inhibitor with IC50 of 5 nM and 10 nM for GSK3β and GSK3α, respectively.

  • KY19382

    KY19382 is a potent and orally active dual inhibitor of CXXC5-DVL and GSK3β( IC50s of 19 and 10 nM, respectively).

  • BIP-135

    BIP-135 is a potent and selective ATP-competitive GSK-3 inhibitor. With IC50s of 16 nM and 21 nM for GSK-3α and GSK-3β, respectively. BIP 135 exhibits neuroprotective effect.